Alpha Tau Medical Ltd (DRTS) — Strategic Asset Allocation Index
Alpha Tau Medical Ltd (DRTS) has a Strategic Asset Allocation Index of 15.9% as of June 2023. Strategic assets (PP&E of $14.71 Million plus long-term investments of $-) total $14.71 Million, measured against net assets of $92.56 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Alpha Tau Medical Ltd to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Alpha Tau Medical Ltd Strategic Asset Allocation Index (2022–2022)
This chart shows how Alpha Tau Medical Ltd's Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of June 2023, the index stands at 15.9%, representing strategic assets of $14.71 Million against net assets of $92.56 Million USD. See DRTS financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Alpha Tau Medical Ltd (2022–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Alpha Tau Medical Ltd from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Alpha Tau Medical Ltd (DRTS) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 12.6% | $13.28 Million | $13.28 Million | $- | $105.66 Million | — |